Showing results (71-80 of 198) with videos related to
Sort By:
Pageof 20
Cancer Science|August 31, 2021
PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinomaSachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, et al.Anticancer Research|February 28, 2023
Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective StudyMarina Abe, Tadahiro Shoji, Yohei Chiba, et al.Cancer Immunology, Immunotherapy : CII|September 16, 2008
Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosisKui Li, Masaki Mandai, Junzo Hamanishi, et al.Gynecologic Oncology|March 23, 2007
Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibitionTsukasa Baba, Masatoshi Kariya, Toshihiro Higuchi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2021
Tumor Immune Microenvironment during Epithelial-Mesenchymal TransitionMana Taki, Kaoru Abiko, Masayo Ukita, et al.Anticancer Research|August 30, 2022
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective StudyShunsuke Tatsuki, Tadahiro Shoji, Marina Abe, et al.BMC Cancer|August 31, 2017
Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneumTakuma Ohsuga, Ken Yamaguchi, Aki Kido, et al.BMC Cancer|October 29, 2014
Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervixMichikazu Nagura, Masafumi Koshiyama, Noriomi Matsumura, et al.Asian Journal of Endoscopic Surgery|January 9, 2026
Safe Trocar Placement by Transvaginal Endoscopic Insertion in Robot-Assisted Surgery for Endometrial Cancer With Umbilical Incisional Hernia and Prior Mesh Repair: Two Case ReportsTakayuki Nagasawa, Nanako Jonai, Minami Oshikiri, et al.Cancers|November 14, 2023
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)Takayuki Nagasawa, Tadahiro Shoji, Eriko Takatori, et al.Pageof 20